We propose a mathematical model explaining the interactions between osteoblasts and osteoclasts, two cell types specialized in the maintenance of the bone integrity. Bone is a dynamic, living tissue whose structure and shape continuously evolves during life. It has the ability to change architecture
Progressive ankylosis protein (ANK) in osteoblasts and osteoclasts controls bone formation and bone remodeling
β Scribed by Hyon Jong Kim; Takeshi Minashima; Edward F McCarthy; Jeffrey A Winkles; Thorsten Kirsch
- Publisher
- American Society for Bone and Mineral Research
- Year
- 2010
- Tongue
- English
- Weight
- 614 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0884-0431
- DOI
- 10.1002/jbmr.60
No coin nor oath required. For personal study only.
β¦ Synopsis
The progressive ankylosis gene (ank) encodes a transmembrane protein that transports intracellular inorganic pyrophosphate (PP~i~) to the extracellular milieu. ank/ank mice, which express a truncated nonfunctional ANK, showed a markedly reduced bone mass, bone-formation rate, and number of tartrate-resistant acid phosphataseβpositive (TRAP^+^) multinucleated osteoclasts. ANK function deficiency suppressed osteoblastic differentiation of ank/ank bone marrow stromal cells, as indicated by the decrease in the expression of bone marker genes, including osterix, reduced alkaline phosphatase activity, and mineralization. Runx2 gene expression levels were not altered. Conversely, overexpression of ANK in the preosteoblastic cell line MC3T3-E1 resulted in increased expression of bone marker genes, including osterix. Whereas runx2 expression was not altered in ANK-overexpressing MC3T3-E1 cells, runx2 transcriptional activity was increased. Extracellular PP~i~ or P~i~ stimulated osteoblastogenic differentiation of MC3T3-E1 cells or partially rescued delayed osteoblastogenic differentiation of ank/ank bone marrow stromal cells. A loss of PP~i~ transport function ANK mutation also stimulated osteoblastogenic differentiation of MC3T3-E1 cells. Furthermore, ANK function deficiency suppressed the formation of multinucleated osteoclasts from ank/ank bone marrow cells cultured in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor-ΞΊB ligand. In conclusion, ANK is a positive regulator of osteoblastic and osteoclastic differentiation events toward a mature osteoblastic and osteoclastic phenotype. Β© 2010 American Society for Bone and Mineral Research.
π SIMILAR VOLUMES
## Abstract Bone remodeling and, therefore, integration of implant materials require the coordinated regulation of osteoblast and osteoclast activity. This is why the __in vitro__ evaluation of biomaterials for bone regeneration should involve not only the analysis of osteoblast differentiation but
## Abstract Bone regeneration is required for fracture healing. Various procedures have been used to promote osteogenesis with bone morphogenetic proteins (BMPs). We assessed the effects of BMPβ2, BMPβ5, and BMPβ6 in isolated and combined use on the generation of osteoblasts and osteoclasts by comp
There is increasing evidence that extracellular nucleotides act on bone cells via multiple P2 receptors. The naturally-occurring ligand ATP is a potent agonist at all receptor subtypes, whereas ADP and UTP only act at specific receptor subtypes. We have reported that the formation and resorptive act